The online home for the primary care professionals managing patients with cardiovascular disease, diabetes and related diseases.

Topic: Diabetes - Primary Care

Thursday, 08 September 2016
Intensified and multifaceted treatment of patients with type 2 diabetes and poor prognosis due to microalbuminuria extends median lifetime by 8 years compared with conventional therapy, according to a new long-term Danish follow-up study of the Steno-2 trial.
Tuesday, 11 April 2017
Type 2 diabetes can be reversed with intensive medical treatment using medications and lifestyle therapies, according to a new study. Up to 40% of study participants were able to stay in remission three months after stopping diabetes medications.
Wednesday, 04 January 2017
A new study suggests that a ‘Sit Less’ intervention ‒ breaking sitting with standing and light-intensity walking ‒ may be an alternative to structured exercise to promote blood sugar control in patients with type 2 diabetes, giving improved 24-hour glucose levels and improved insulin sensitivity.
Friday, 30 June 2017
The leading UK cardiovascular conference for the whole primary care team. Expert presenters and a down-to-earth approach help health professionals translate the latest evidence into daily practice and optimise patient care. Participants also receive 9 hours CPD credits. Book now to attend this inspirational event and take advantage of our Early Bird discount.
Category: Editorial
Friday, 19 May 2017
A national drive to prevent type 2 diabetes could help delay or stop up to 18,000 cases of the condition from developing over five years. The NHS Diabetes Prevention Programme (NHS DPP) could also save £1.1 billion in health benefits and by year 12 could become cost saving. The programme was developed to identify those at high risk of type 2 diabetes and refer them onto a behaviour change programme.
Category: Have You Heard
Sunday, 12 March 2017
For the first time the European Commission has approved the use of a diabetes treatment for its effect on both blood sugar and cardiovascular events. Empagliflozin product information now includes data on the reduction of risk of cardiovascular death in addition to data on the improvement of blood sugar control.
Category: Have You Heard
Wednesday, 06 December 2017
Updated NICE guidance recommends that healthcare professionals should refer people with elevated blood sugars to exercise classes and nutrition courses. The updated guidelines Type 2 diabetes: prevention in people at high risk can be used alongside the NHS Health Check programme
Category: Have You Heard
Thursday, 02 February 2017
Liraglutide 1.2 mg has proved cost-effective when compared to alternative daily administered GLP-1 receptor agonists for the treatment of type 2 diabetes in the UK.
Friday, 15 September 2017
Moderate yet frequent alcohol consumption is associated with a reduced risk of diabetes in both men and women, with alcohol consumption over 3–4 week days giving the lowest risk.

Article search and filter